{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T23:51:20Z","timestamp":1785541880073,"version":"3.56.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.ijrobp.2010.05.066","type":"journal-article","created":{"date-parts":[[2010,10,2]],"date-time":"2010-10-02T04:41:49Z","timestamp":1285994509000},"page":"506-510","source":"Crossref","is-referenced-by-count":7,"title":["Adverse Events in the Long-Term Follow-Up of Patients Treated With Samarium Sm 153 Lexidronam for Osseous Metastases"],"prefix":"10.1016","volume":"81","author":[{"given":"Anthony J.","family":"Paravati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea L.","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Candice","family":"Aitken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2010.05.066_bib1","doi-asserted-by":"crossref","first-page":"6243s","DOI":"10.1158\/1078-0432.CCR-06-0931","article-title":"Clinical features of metastatic bone disease and risk of skeletal morbidity","volume":"12","author":"Coleman","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2010.05.066_bib2","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1053\/ctrv.2000.0210","article-title":"Metastatic bone disease: Clinical features, pathophysiology and treatment strategies","volume":"27","author":"Coleman","year":"2001","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.ijrobp.2010.05.066_bib3","doi-asserted-by":"crossref","first-page":"101S","DOI":"10.1016\/8756-3282(95)00194-I","article-title":"Bone and cancer: Pathophysiology and treatment of metastases","volume":"17","author":"Kanis","year":"1995","journal-title":"Bone"},{"key":"10.1016\/j.ijrobp.2010.05.066_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0304-3959(96)03267-8","article-title":"Malignant bone pain: Pathophysiology and treatment","volume":"69","author":"Mercadante","year":"1997","journal-title":"Pain"},{"key":"10.1016\/j.ijrobp.2010.05.066_bib5","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1080\/02841860310014895","article-title":"A systematic overview of radiation therapy effects in skeletal metastases","volume":"42","author":"Falkmer","year":"2003","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ijrobp.2010.05.066_bib6","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1200\/JCO.1998.16.4.1574","article-title":"Palliation of pain associated with metastatic bone cancer using samarium-153 lexidronam: A double-blind placebo-controlled clinical trial","volume":"16","author":"Serafini","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2010.05.066_bib7","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.urology.2004.01.034","article-title":"Samarium-153-Lexidronam complex for treatment of painful bone metastases in hormone-refractory prostate cancer","volume":"63","author":"Sartor","year":"2004","journal-title":"Urology"},{"key":"10.1016\/j.ijrobp.2010.05.066_bib8","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1200\/JCO.2008.18.9811","article-title":"Phase II trial of consolidation docetaxel and samarium-153 in patients with bone metastases from castration-resistant prostate cancer","volume":"27","author":"Fizazi","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2010.05.066_bib9","unstructured":"Lin J, Sinibaldi VJ, Carducci MA, et\u00a0al. Phase I trial with a combination of docetaxel and (153)Sm-lexidronam in patients with castration-resistant metastatic prostate cancer. Urol Oncol. In press."},{"key":"10.1016\/j.ijrobp.2010.05.066_bib10","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1200\/JCO.2008.20.4164","article-title":"Phase I study of samarium-153 lexidronam with docetaxel in castration-resistant metastatic prostate cancer","volume":"27","author":"Morris","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2010.05.066_bib11","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1200\/JCO.2008.20.5393","article-title":"Phase I study of concurrent weekly docetaxel and repeated samarium-153 lexidronam in patients with castration-resistant metastatic prostate cancer","volume":"27","author":"Tu","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2010.05.066_bib12","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1088\/0031-9155\/5\/1\/307","article-title":"A summary of the data of Mechanik on the distribution of human bone marrow","volume":"5","author":"Woodard","year":"1960","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ijrobp.2010.05.066_bib13","series-title":"CTCAE v3","year":"2006"},{"key":"10.1016\/j.ijrobp.2010.05.066_bib14","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1093\/annonc\/mdn178","article-title":"Myelotoxicity of samarium Sm 153 lexidronam in patients receiving prior treatment with chemotherapy or radiotherapy","volume":"19","author":"Heron","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2010.05.066_bib15","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.jpainsymman.2004.07.008","article-title":"Palliation of bone pain in prostate cancer using chemotherapy and strontium-89. A randomized phase II study","volume":"29","author":"Nilsson","year":"2005","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.ijrobp.2010.05.066_bib16","doi-asserted-by":"crossref","first-page":"7904","DOI":"10.1200\/JCO.2005.01.2310","article-title":"Therapy tolerance in selected patients with androgen-independent prostate cancer following strontium-89 combined with chemotherapy","volume":"23","author":"Tu","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2010.05.066_bib17","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1023\/A:1008245400251","article-title":"Clinical characteristics of severe peripheral neuropathy induced by docetaxel (Taxotere)","volume":"8","author":"Hilkens","year":"1997","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2010.05.066_bib18","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1200\/JCO.2002.20.3.867","article-title":"Challenges in oncology. Case 2. Radiation recall associated with docetaxel","volume":"20","author":"Morkas","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2010.05.066_bib19","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S0959-8049(96)00461-3","article-title":"Radiation-recall dermatitis with docetaxel: Establishment of a requisite radiation threshold","volume":"33","author":"Yeo","year":"1997","journal-title":"Eur J Cancer"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301610008217?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301610008217?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,5]],"date-time":"2019-06-05T01:31:29Z","timestamp":1559698289000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301610008217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0360301610008217"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2010.05.066","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}